Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer

Kyoichi Kaira; Yutaka Sunose; Yasuhiro Ohshima; Noriko S. Ishioka; Kazuhisa Arakawa; Tetsushi Ogawa; Noriaki Sunaga; Kimihiro Shimizu; Hideyuki Tominaga; Noboru Oriuchi; Hideaki Itoh; Shushi Nagamori; Yoshikatsu Kanai; Aiko Yamaguchi; A Segawa; Munenori Ide; Masatomo Mori; Tetsunari Oyama; Izumi Takeyoshi

doi:10.1186/1471-2407-13-482

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

High expression of LAT1 is a promising pathological marker to predict the outcome in patients with biliary tract adenocarcinoma. Inhibition of LAT1 may be an effective targeted therapy for this distressing disease.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kaira et al. (2013) studied this question.

synapsesocial.com/papers/69de6e29210a0977fce9429f https://doi.org/10.1186/1471-2407-13-482

View Full Paper

Ask AI

Bookmark

Share

Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer

Ask about this paper

Abstract

Discussion

Cite This Study

Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading